View Older Stories View More Recent Stories

Jan 25, 2024 07:00AM Labrador Gold Intersects 0.87g/t Au Over 55.9 Metres at New HM Occurrence Includes 38.37g/t Au Over 0.8 Meters
Jan 8, 2024 08:34AM Standard BioTools (LAB) Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Jan 8, 2024 08:30AM Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Jan 5, 2024 08:47AM Standard BioTools (LAB) Completes Merger with SomaLogic (SLGC)
Jan 5, 2024 08:46AM Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools
Jan 4, 2024 10:23PM Standard BioTools Stockholders Approve Merger with SomaLogic
Dec 29, 2023 05:10PM Glass Lewis Recommends Standard BioTools (LAB) Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic (SLGC)
Dec 29, 2023 05:04PM Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
Dec 26, 2023 04:05AM ISS Recommends Standard BioTools (LAB) Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic (SLGC)
Dec 22, 2023 06:57PM ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
Dec 21, 2023 08:03AM Somalogic (SLGC) Issues Letter to Stockholders
Dec 21, 2023 08:00AM SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
Dec 4, 2023 08:00AM Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
Nov 22, 2023 07:30AM Labrador Gold Exercises Option to Acquire 100% of the Hopedale Property
Nov 7, 2023 04:00PM Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
Nov 2, 2023 08:30AM Standard BioTools to Present at the Jefferies London Healthcare Conference
Oct 25, 2023 08:30AM Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023
Oct 19, 2023 07:30AM Labrador Gold Receives Permits to Drill Targets in the Gap and Kingsway South
Oct 4, 2023 08:01AM Standard BioTools (LAB) and SomaLogic (SLGC) to Combine in All-Stock Merger
Oct 4, 2023 08:00AM Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
Aug 16, 2023 07:30AM Labrador Gold Reports High Grade Gold Assays Up to 30.58g/t Au Between Big Vein and Golden Glove
Aug 9, 2023 07:30AM Labrador Gold Intersects 11.98g/t Au Over 6 Metres Including 30.61g/t Over 2.33 Metres in Follow Up Drilling at Pristine
Aug 8, 2023 04:05PM Standard BioTools Reports Second Quarter 2023 Financial Results
Jul 26, 2023 04:05PM Standard BioTools to Participate in Upcoming Investor Conferences
Jul 25, 2023 04:05PM Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
Jun 14, 2023 07:30AM Standard BioTools to Participate in Upcoming Investor Conferences
May 25, 2023 04:05PM Standard BioTools to Present at the Jefferies Healthcare Conference
May 18, 2023 07:30AM Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System
May 15, 2023 07:30AM Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 9, 2023 04:05PM Standard BioTools Reports First Quarter 2023 Financial Results
Apr 25, 2023 04:30PM Standard BioTools Announces Conference Call and Webcast for First Quarter 2023 Financial Results
Apr 20, 2023 05:03PM Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 20, 2023 08:00AM Labrador Gold Intersects 5.22g/t Au Over 2.8M Including 22.02g/t Over 0.4M
Apr 17, 2023 08:30AM Standard BioTools introduces the Hyperion XTi Imaging System, breaks barriers to power significant advancement in spatial biology
Apr 4, 2023 08:00AM Labrador Gold Announces Results of Annual General Meeting of Shareholders
Mar 22, 2023 08:30AM Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 15, 2023 08:33AM Standard BioTools (LAB) Appoints Fenel Eloi to its Board
Mar 15, 2023 08:30AM Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors
Mar 14, 2023 08:30AM Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 2, 2023 08:00AM Labrador Gold Intersects 2.32 g/t Au Over 18.6 Metres at Big Vein
Mar 1, 2023 04:05PM Standard BioTools to Present at 43rd Annual Cowen Health Care Conference
Feb 21, 2023 08:30AM Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 14, 2023 04:05PM Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook
Jan 31, 2023 08:30AM Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results
Jan 19, 2023 08:00AM Labrador Gold Announces High-Grade Gold and Copper Assays From Hopedale Project Including 21.59 g/t Au From TD500 and 10.2% Cu From Kaapak
Jan 12, 2023 08:00AM Labrador Gold Intersects 20.88 g/t Au Over 5 Metres at Big Vein, Kingsway Project
Jan 9, 2023 08:36AM Standard BioTools (LAB) Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Jan 9, 2023 08:30AM Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Jan 3, 2023 08:30AM Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer
Dec 30, 2022 08:00AM Labrador Gold Reviews Successful Year of Discovery at Kingsway
View More Recent Stories View Older Stories